SEPSF — Asep Medical Holdings Inc.
—
OTC ·
Health Care ·
Life Sciences Tools & Services ·
CIK 1969766 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 74,803 | 88,642 | -571,173 | -486,405 | 13,475,042 | 510,627 | 4,086,101 |
| Sep 2024 | 74,803 | 41,053 | -811,007 | -733,367 | 24,300,006 | 12,284 | 4,418,777 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-658,289
Investing CF
$949,373
Financing CF
$165,487
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.14
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-25,437,901
Inventory
—
Receivables
$14,750
ST Investments
—
EBIT TTM
$-1,494,163
Pretax Income TTM
$-1,501,411
Interest Exp TTM
$7,248
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$296,773
EBITDA
$-1,647,635
Free Cash Flow
$-1,099,786
Enterprise Value
$4,439,477
Total Cash
$718,220
Total Debt
$727,039
Shares Out
11,123,729
Trailing EPS
$-0.71
Book Value
$0.33
ROE
-88.0%
ROA
-8.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2023 | 21,140 | -7,721,263 | -8,227,328 | 25,612,686 | 3,051,861 | — | -2,712,598 |
| Dec 2022 | 0 | -5,442,652 | -4,524,981 | 27,078,589 | 528,161 | — | -3,614,476 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IDXX | IDEXX LABORATORIES INC /DE | $43.95B | $557.21 | — |
| IQV | IQVIA HOLDINGS INC. | $27.04B | $162.00 | — |
| INCY | INCYTE CORP | $19.40B | $97.10 | — |
| MEDP | Medpace Holdings, Inc. | $12.26B | $429.11 | — |
| ICLR | ICON PLC | $8.69B | $113.85 | — |
Recent Insider Activity
No insider activity indexed for this ticker.